Diagnostic contribution of EBUS in Interstitial Lung Desease (excluding Sarcoidosis)

W. Khamis (Bobigny, France), D. Basille (Amiens, France), J. Bernaudin (Bobigny, France), J. Morvan (Amiens, France), M. Soussan (Bobigny, France), M. Auquier (Amiens, France), K. Levand (Bobigny, France), P. Brillet (Bobigny, France), E. Magois (Amiens, France), C. Dayen (Saint-Quentin , France), Y. Douadi (Saint-Quentin , France), D. Valeyre (Bobigny, France), V. Jounieaux (Amiens, France), H. Nunes (Bobigny, France), O. Freynet (Bobigny, France)

Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF)
Session: Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF)
Session type: Thematic Poster
Number: 2947
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
W. Khamis (Bobigny, France), D. Basille (Amiens, France), J. Bernaudin (Bobigny, France), J. Morvan (Amiens, France), M. Soussan (Bobigny, France), M. Auquier (Amiens, France), K. Levand (Bobigny, France), P. Brillet (Bobigny, France), E. Magois (Amiens, France), C. Dayen (Saint-Quentin , France), Y. Douadi (Saint-Quentin , France), D. Valeyre (Bobigny, France), V. Jounieaux (Amiens, France), H. Nunes (Bobigny, France), O. Freynet (Bobigny, France). Diagnostic contribution of EBUS in Interstitial Lung Desease (excluding Sarcoidosis). 2947

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
EBUS vs EUS-B for diagnosing sarcoidosis:the International Sarcoidosis Assessment (ISA) RCT
Source: International Congress 2018 – EUS-B and EBUS: optimal utilisation of the EBUS scope
Year: 2018

Gender perspective in Interstitial Lung Diseases (ILD)
Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment
Year: 2019

Usefulness of electronic nose in detection of Interstitial Lung Diseases (ILD)
Source: International Congress 2019 – Biomarkers and beyond in idiopathic interstitial pneumonia
Year: 2019

Impact of a Bayesian approach on the diagnosis of Interstitial Lung Diseases
Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia
Year: 2019


Diagnostic impact of EUS(b)-FNA in diagnostics of sarcoidosis
Source: Annual Congress 2013 –TBNA, EBUS-TBNA and new technologies for diagnostic bronchoscopy
Year: 2013

Benefit of steroid-free treatment compared to standard therapy (ST) in pulmonary sarcoidosis
Source: International Congress 2014 – ILDs 5
Year: 2014


Combined pulmonary fibrosis and emphysema: A report from the Hellenic Interstitial Lung Diseases group
Source: Annual Congress 2010 - Different patterns of interstitial lung disease
Year: 2010


Diagnosis of cardiac sarcoidosis: A crossectional study in 327 consecutive patients
Source: International Congress 2014 – Sarcoidosis
Year: 2014

Transbronchial Criobiopsy (TCB) In Two Lung Lobes- Diagnostic Accuracy
Source: International Congress 2017 – ILDs: clinical aspects
Year: 2017

Synoptical table of idiopathic interstital pneumonia (IIP) findings in computed tomography (CT) – A practical tool and systematic review
Source: International Congress 2014 – ILDs 5
Year: 2014


Predictive Findings of Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021


Diagnostic value of cervical mediastinoscopy: Report of 506 cases
Source: Annual Congress 2013 –Oncological thoracic surgery
Year: 2013


Sarcoidosisandpulmonarydust: Mineralogical analysis (MA) and optical microscopy (OM)
Source: International Congress 2014 – Sarcoidosis
Year: 2014


Neuroendocrine cell hyperplasia (NEHI) and NEHI Syndrome: Lung biopsy necessary?
Source: International Congress 2014 – ILDs 4
Year: 2014


Experience of endobronchial ultrasound - transbronchial needle aspiration (EBUS-TBNA) in granulomatous disease
Source: International Congress 2014 – Sarcoidosis
Year: 2014


The incidence of Progressive Fibrotic Interstitial Lung Diseases (PFILD) treatable with oral-antifibrotic therapy in a UK Specialist Interstitial Lung Disease clinic.
Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more
Year: 2020


Provident Diagnostic Method for Interstitial Lung Disease: Awake Uniportal Videothoracoscopy
Source: International Congress 2017 – Thoracic surgery
Year: 2017

Value of community based Pulmonary Rehabilitation (PR) for patients with Interstitial Lung Disease (ILD): A retrospective review
Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases
Year: 2019


Ultrasound guided transthoracic biopsy performed by respiratory physicians: Diagnostic yield and complications
Source: International Congress 2015 – Transbronchial and percutaneous approach to peripheral pulmonary lesions
Year: 2015